Entresto Copay Card & Savings Guide: 2026
Entresto (sacubitril/valsartan) is a cornerstone heart-failure medication — and one where the cost landscape changed more in the last two years than in the previous eight. A Medicare-negotiated price took effect, the first generics began arriving, and the copay card kept its unusually generous terms. Whatever you were told Entresto costs in 2023, re-check it: the real Entresto cost in 2026 is probably lower on every path.
What you’ll pay with the Entresto copay card
With the Entresto coupon — the official Novartis copay card — eligible commercially insured patients can get a 30-, 60-, or 90-day supply for as little as $10 total, with assistance capped at $4,100 per calendar year. [1] That cap is generous relative to typical copays, and the flat-$10-regardless-of-supply-length structure makes 90-day fills the obvious value play.
Standard fine print: the card pays down your copay to the floor only within its per-fill and annual limits — high-deductible plans can see pricier early-year fills before the math settles, and it’s worth asking your plan whether card payments count toward your deductible (some run “accumulator” programs that don’t credit them). Enrollment is at the official Entresto site; re-enroll each calendar year.
Who qualifies: commercial insurance with a valid prescription, 18+. Excluded: Medicare, Medicaid, TRICARE, VA — federal rules, not Novartis’s choice. If that’s you, keep reading; your section got better.
The Entresto Medicare price: the 2026 game-changer
Entresto was in the first group of ten drugs subject to Medicare price negotiation, and the negotiated price took effect January 2026: $295 for a 30-day supply — roughly 53% below the 2023 list price. [2] Stack on the redesigned Part D benefit’s annual out-of-pocket cap and the Medicare Prescription Payment Plan (which spreads costs evenly across the year — ask your plan to enable it), and the Medicare picture has genuinely transformed.
Your actual copay still depends on your plan’s tier and phase of coverage, so the move is one phone call: ask your Part D plan what you’ll pay for Entresto this year. Lower-income beneficiaries should also check Extra Help (the Low-Income Subsidy) — it reduces Part D costs substantially and enrollment is far easier than most people assume.
Generic Entresto: finally real — price it
Generic sacubitril/valsartan reached U.S. pharmacies in mid-2025, and multiple manufacturers (Novadoz, Torrent, Camber, Ascend, and others) now produce all three strengths. Pricing has already fallen hard: cash prices run roughly $45–$255 per 30-day supply, and pharmacy discount cards routinely bring it to $30–$55 — against a brand retail near $650. So the practical advice is unglamorous: ask your pharmacy to price the generic against your brand-with-card copay, and take whichever is actually cheaper. With the card’s $10 floor, brand may still win for the commercially insured this year; for cash payers and some Medicare tiers, the generic may already be the answer. Recheck at each refill era — this comparison will keep shifting in the generic’s favor.
Entresto patient assistance: uninsured or falling through the gaps
The Novartis Patient Assistance Foundation provides Entresto at no cost to uninsured and underinsured patients who qualify by income — recent Entresto income grids ran around 400% of the Federal Poverty Level, and the foundation confirms current numbers at 1-800-277-2254. [3] Standard application shape — income documentation, prescriber section, weeks not days, annual renewal — with mechanics covered in our patient assistance guide.
While anything processes: ask your cardiologist’s office about samples, and say the actual sentence — “I can’t afford this fill” — out loud. Heart-failure teams have bridged this gap a hundred times, and the alternative patients choose silently (stretching doses) is the one outcome everyone is trying to prevent: stopping or rationing a heart-failure medication risks decompensation and hospitalization that no copay ever justified.
The rest of the toolkit
- 90-day fills — the card’s flat $10 makes them the best value; many plans also tier them favorably.
- Related heart medications have their own programs — if you’re also on Eliquis for atrial fibrillation, its copay card and assistance options stack alongside Entresto’s; every drug’s program is a separate enrollment.
- HSA/FSA funds apply to out-of-pocket costs.
- Watch the calendar: card renewal, plan formulary changes, and the generic’s price trajectory all reset in January. A ten-minute review each new year is worth real money on this drug.
Frequently Asked Questions
How much is Entresto with the copay card?
Eligible commercially insured patients can get a 30-, 60-, or 90-day supply for as little as $10 total, with copay assistance capped at $4,100 per calendar year.
What is the Entresto Medicare price in 2026?
Entresto was in the first group of Medicare-negotiated drugs: the negotiated price for a 30-day supply is $295 in 2026 — about 53% below the old list price — and Part D’s annual out-of-pocket cap applies on top. Your actual copay depends on your plan’s tier.
Is there a generic for Entresto?
Yes — generic sacubitril/valsartan launched in mid-2025 and multiple manufacturers now make it, with pharmacy discount-card prices as low as $30–$55 a month. Price the generic against your brand-with-card copay, and take whichever is genuinely cheaper.
Can Medicare patients use the Entresto copay card?
No — federal rules exclude Medicare, Medicaid, and other government programs from manufacturer copay cards. Between the negotiated $295 price, the Part D cap, Extra Help subsidies, and Novartis patient assistance, Medicare patients still have real options.
What happens if I stop taking Entresto because of cost?
Stopping a heart-failure medication abruptly risks decompensation — worsening symptoms and hospitalization that dwarf any copay. If cost is forcing the choice, call your prescriber and the assistance programs first; bridging options exist for exactly this situation.
Sources
This guide covers cost and access, not medical advice — talk to your prescriber before changing how you take Entresto. Program terms, prices, and eligibility change without notice; confirm current details with the official program (linked in the sources above) before relying on them. We’re an independent publisher, not affiliated with or endorsed by Novartis — see our full medical disclaimer.